Overall, Statista predicted the worldwide pharma industry market revenue will increase 4.5% between 2024 and 2025.
Oncology medication revenue is projected to grow 7.6%, reaching $208.86 billion in 2025. Other lucrative pharmaceutical markets in 2025 include:
- Anti-diabetes drugs — $84.48 billion (8.3% growth from 2024)
- Vaccines — $69.21 billion (-6.6%)
- Immunosuppressants — $61.05 billion (15.1%)
- Antiviral drugs — $52.19 billion (2%)
- Anti-rheumatic drugs — $47.33 billion (-0.7%)
By 2026, Statista predicted the cell therapy market will reach $87.22 billion, gene therapies will reach $13.25 billion and nucleic acid therapies will hit $1.35 billion.
Oncology is expected to account for the largest chunk of the next generation of therapeutic areas, with a projected $62.54 billion market value. The other leading therapeutic areas are expected to be multiple sclerosis ($12.66 billion) and inflammatory rheumatism ($5.77 billion).
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
